Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05007561Phase 1Completed
Phase 1, randomised, double-blind trial comparing Naltrexone with Placebo (2 arms). Primary endpoints: Daily feelings of social connection, Bold Oxygen-level Dependent (BOLD) Activations in Prespecified ROIs at Day 7 and 1 more. Started Nov 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05007561.